6.
Bilezikian J, Watts N, Usiskin K, Polidori D, Fung A, Sullivan D
. Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin. J Clin Endocrinol Metab. 2015; 101(1):44-51.
PMC: 4701848.
DOI: 10.1210/jc.2015-1860.
View
7.
Nilsson A, Sundh D, Johansson L, Nilsson M, Mellstrom D, Rudang R
. Type 2 Diabetes Mellitus Is Associated With Better Bone Microarchitecture But Lower Bone Material Strength and Poorer Physical Function in Elderly Women: A Population-Based Study. J Bone Miner Res. 2016; 32(5):1062-1071.
DOI: 10.1002/jbmr.3057.
View
8.
Farr J, Drake M, Amin S, Melton 3rd L, McCready L, Khosla S
. In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res. 2013; 29(4):787-95.
PMC: 3961509.
DOI: 10.1002/jbmr.2106.
View
9.
Buie H, Campbell G, Klinck R, Macneil J, Boyd S
. Automatic segmentation of cortical and trabecular compartments based on a dual threshold technique for in vivo micro-CT bone analysis. Bone. 2007; 41(4):505-15.
DOI: 10.1016/j.bone.2007.07.007.
View
10.
Vestergaard P
. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int. 2006; 18(4):427-44.
DOI: 10.1007/s00198-006-0253-4.
View
11.
Samelson E, Demissie S, Cupples L, Zhang X, Xu H, Liu C
. Diabetes and Deficits in Cortical Bone Density, Microarchitecture, and Bone Size: Framingham HR-pQCT Study. J Bone Miner Res. 2017; 33(1):54-62.
PMC: 5771832.
DOI: 10.1002/jbmr.3240.
View
12.
Starr J, Bandeira L, Agarwal S, Shah A, Nishiyama K, Hu Y
. Robust Trabecular Microstructure in Type 2 Diabetes Revealed by Individual Trabecula Segmentation Analysis of HR-pQCT Images. J Bone Miner Res. 2018; 33(9):1665-1675.
PMC: 6119094.
DOI: 10.1002/jbmr.3465.
View
13.
Ye Y, Zhao C, Liang J, Yang Y, Yu M, Qu X
. Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Bone Metabolism and Fracture Risk. Front Pharmacol. 2019; 9:1517.
PMC: 6331441.
DOI: 10.3389/fphar.2018.01517.
View
14.
Furst J, Bandeira L, Fan W, Agarwal S, Nishiyama K, McMahon D
. Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes. J Clin Endocrinol Metab. 2016; 101(6):2502-10.
PMC: 4891790.
DOI: 10.1210/jc.2016-1437.
View
15.
Paccou J, Ward K, Jameson K, Dennison E, Cooper C, Edwards M
. Bone Microarchitecture in Men and Women with Diabetes: The Importance of Cortical Porosity. Calcif Tissue Int. 2015; 98(5):465-73.
DOI: 10.1007/s00223-015-0100-8.
View
16.
Schwartz A, Vittinghoff E, Bauer D, Hillier T, Strotmeyer E, Ensrud K
. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011; 305(21):2184-92.
PMC: 3287389.
DOI: 10.1001/jama.2011.715.
View
17.
Samelson E, Broe K, Xu H, Yang L, Boyd S, Biver E
. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study. Lancet Diabetes Endocrinol. 2018; 7(1):34-43.
PMC: 6354581.
DOI: 10.1016/S2213-8587(18)30308-5.
View
18.
Wang X, Zhang F, Zhang Y, Zhang J, Sheng Y, Wang W
. Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Osteoporos Int. 2023; 34(12):2013-2025.
DOI: 10.1007/s00198-023-06908-2.
View
19.
Rieg T, Masuda T, Gerasimova M, Mayoux E, Platt K, Powell D
. Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia. Am J Physiol Renal Physiol. 2013; 306(2):F188-93.
PMC: 3920019.
DOI: 10.1152/ajprenal.00518.2013.
View
20.
Burghardt A, Issever A, Schwartz A, Davis K, Masharani U, Majumdar S
. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010; 95(11):5045-55.
PMC: 2968722.
DOI: 10.1210/jc.2010-0226.
View